Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Current Assets (2016 - 2025)

Nephros (NEPH) has 16 years of Current Assets data on record, last reported at $10.7 million in Q3 2025.

  • For Q3 2025, Current Assets rose 45.54% year-over-year to $10.7 million; the TTM value through Sep 2025 reached $10.7 million, up 45.54%, while the annual FY2024 figure was $8.3 million, 1.27% down from the prior year.
  • Current Assets reached $10.7 million in Q3 2025 per NEPH's latest filing, up from $9.6 million in the prior quarter.
  • Across five years, Current Assets topped out at $14.8 million in Q2 2021 and bottomed at $7.4 million in Q3 2024.
  • Average Current Assets over 5 years is $10.1 million, with a median of $9.0 million recorded in 2025.
  • Peak YoY movement for Current Assets: tumbled 39.41% in 2022, then soared 45.54% in 2025.
  • A 5-year view of Current Assets shows it stood at $13.6 million in 2021, then crashed by 39.41% to $8.3 million in 2022, then grew by 1.74% to $8.4 million in 2023, then decreased by 1.27% to $8.3 million in 2024, then rose by 29.02% to $10.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $10.7 million in Q3 2025, $9.6 million in Q2 2025, and $9.0 million in Q1 2025.